Building smarter antibody optimization strategies in the AI era

From target to production: how to design your strategy to reduce clinical development risks through AI-reshaped approaches.

Webinar - April 28, 2026

5 pm CEST (Paris) - 4 pm BST (London), 11 am EDT (New York), 8 am PDT (Los Angeles)

Key takeaways

● A successful antibody candidate must balance multiple parameters

● Different optimization strategy design can be tailored and combined depending on the project's stage and constraints

● The most effective optimization workflows combine AI with bioinformatics expertise and experimental validation to reduce cost and save time. A practical framework can help determine when optimization is needed and which strategy is most relevant

 ● A downloadable guide supports post-webinar evaluation of whether a therapeutic antibody is sufficiently optimized to reduce clinical develoment risk